Ajanta Pharma informs about disclosure
Ajanta Pharma has informed that it enclosed Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 06, 2026 for Aayush Agrawal, Trustee Aayush Agrawal Trust.
The above information is a part of company’s filings submitted to BSE.
